title: Response of fibroblastic rheumatism to infliximab.
abstract: Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.
authors.affiliation: Departments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, Brazil.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Romiti
authors.forename: Mauricio
authors.initials: M
authors.lastname: Levy Neto
authors.forename: Marcello
authors.initials: M
authors.lastname: Menta Simonsen Nico